Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Tribalto

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
Blood|September 10, 1998
The Italian experience on interferon as maintenance treatment in multiple myeloma: ten years afterA Pulsoni, G Avvisati, M T Petrucci, et al.
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|July 1, 1988
[Current aspects of treatment of multiple myeloma]M Tribalto, G Avvisati, M Cantonetti, et al.
Haematologica|September 1, 1991
Mitoxantrone in combination with etoposide and cytarabine for treatment of poor prognosis acute non lymphoid leukemia patientsM Tribalto, M Cantonetti, G Catalano, et al.
Tumori|December 31, 1992
Simultaneous occurrence of monoclonal gammopathy and acute secondary leukemia with overexpression of P-glycoproteinR Stasi, M Tribalto, A Venditti, et al.
Cancer Genetics and Cytogenetics|October 1, 1995
Cytogenetic analysis is non-informative for assessing the remission rate in chronic myeloid leukemia (CML) patients on interferon-alpha (IFN-alpha) therapyM C Cox-Froncillo, M Cantonetti, M Masi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1989
Early responder myeloma: kinetic studies identify a patient subgroup characterized by very poor prognosisM Boccadoro, F Marmont, M Tribalto, et al.
European Journal of Haematology|March 1, 1994
Classification of patients affected by multiple myeloma using a neural network softwareR Bugliosi, M Tribalto, G Avvisati, et al.
British Journal of Haematology|December 1, 1984
Low plasma cell 3(H) thymidine incorporation in monoclonal gammopathy of undetermined significance (MGUS), smouldering myeloma and remission phase myeloma: a reliable indicator of patients not requiring therapyM Boccadoro, P Gavarotti, G Fossati, et al.
Leukemia|July 1, 1995
All-trans retinoic acid and low-dose cytosine arabinoside for the treatment of 'poor prognosis' acute myeloid leukemiaA Venditti, R Stasi, G Del Poeta, et al.
The International Journal of Artificial Organs|December 1, 1993
Treatment of multiple myeloma with autologous blood stem cell transplantation. Preliminary results of an Italian multicentric pilot studyM Tribalto, G Papa, U Coppetelli, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Blood|September 10, 1998
The Italian experience on interferon as maintenance treatment in multiple myeloma: ten years afterA Pulsoni, G Avvisati, M T Petrucci, et al.
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|July 1, 1988
[Current aspects of treatment of multiple myeloma]M Tribalto, G Avvisati, M Cantonetti, et al.
Haematologica|September 1, 1991
Mitoxantrone in combination with etoposide and cytarabine for treatment of poor prognosis acute non lymphoid leukemia patientsM Tribalto, M Cantonetti, G Catalano, et al.
Tumori|December 31, 1992
Simultaneous occurrence of monoclonal gammopathy and acute secondary leukemia with overexpression of P-glycoproteinR Stasi, M Tribalto, A Venditti, et al.
Cancer Genetics and Cytogenetics|October 1, 1995
Cytogenetic analysis is non-informative for assessing the remission rate in chronic myeloid leukemia (CML) patients on interferon-alpha (IFN-alpha) therapyM C Cox-Froncillo, M Cantonetti, M Masi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1989
Early responder myeloma: kinetic studies identify a patient subgroup characterized by very poor prognosisM Boccadoro, F Marmont, M Tribalto, et al.
European Journal of Haematology|March 1, 1994
Classification of patients affected by multiple myeloma using a neural network softwareR Bugliosi, M Tribalto, G Avvisati, et al.
British Journal of Haematology|December 1, 1984
Low plasma cell 3(H) thymidine incorporation in monoclonal gammopathy of undetermined significance (MGUS), smouldering myeloma and remission phase myeloma: a reliable indicator of patients not requiring therapyM Boccadoro, P Gavarotti, G Fossati, et al.
Leukemia|July 1, 1995
All-trans retinoic acid and low-dose cytosine arabinoside for the treatment of 'poor prognosis' acute myeloid leukemiaA Venditti, R Stasi, G Del Poeta, et al.
The International Journal of Artificial Organs|December 1, 1993
Treatment of multiple myeloma with autologous blood stem cell transplantation. Preliminary results of an Italian multicentric pilot studyM Tribalto, G Papa, U Coppetelli, et al.
Pageof 7